Is VistaGen Therapeutics, Inc. technically bullish or bearish?

Sep 20 2025 07:51 PM IST
share
Share Via
As of August 26, 2025, VistaGen Therapeutics, Inc. shows a bullish technical trend with mixed momentum indicators, underperforming the S&P 500 year-to-date and over the past year.
As of 26 August 2025, the technical trend for VistaGen Therapeutics, Inc. has changed from sideways to bullish. The weekly MACD is bullish, and the daily moving averages are also bullish, indicating positive momentum. However, the monthly MACD is only mildly bullish, and the Bollinger Bands show a bearish stance on the monthly timeframe. The KST is bullish weekly but bearish monthly, while the Dow Theory indicates a mildly bullish trend in both weekly and monthly perspectives. The OBV presents a mixed view, being mildly bearish weekly but bullish monthly.

In terms of performance, VistaGen has underperformed compared to the S&P 500 across multiple periods, with a year-to-date return of 3.05% versus 12.22% for the S&P 500, and a one-year return of 1.50% compared to 17.14% for the index. Overall, the current technical stance is bullish, but the strength is mixed, with some indicators showing caution.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is VistaGen Therapeutics, Inc. overvalued or undervalued?
Sep 20 2025 06:26 PM IST
share
Share Via
Is VistaGen Therapeutics, Inc. overvalued or undervalued?
Jun 25 2025 09:04 AM IST
share
Share Via
What does VistaGen Therapeutics, Inc. do?
Jun 22 2025 06:48 PM IST
share
Share Via
How big is VistaGen Therapeutics, Inc.?
Jun 22 2025 06:05 PM IST
share
Share Via